Notice: This company has been marked as potentially delisted and may not be actively trading. Bellicum Pharmaceuticals (BLCM) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Bellicum Pharmaceuticals Inc (OTC:BLCM) Stock Quotes, Forecast and News SummaryOctober 14, 2024 | benzinga.comBellicum sells assets to MD Anderson, moves towards liquidationFebruary 22, 2024 | msn.comBellicum Pharmaceuticals Issues Super-Voting Share PrivatelyJanuary 25, 2024 | msn.comBellicum Pharmaceuticals Inc BLCMDecember 23, 2023 | morningstar.comBellicum Pharmaceuticals Stock (OTC:BLCM), Short Interest ReportDecember 8, 2023 | benzinga.comFutura Medical plc (FAMDF)October 27, 2023 | finance.yahoo.comBLCM - Bellicum Pharmaceuticals, Inc.July 13, 2023 | finance.yahoo.comBellicum Pharmaceuticals (NASDAQ: BLCM)June 3, 2023 | fool.comTrading was temporarily halted for "BLCM" at 09:05 AM with a stated reason of "LULD pause." Trading set to resume at 09:05 AM. May 8, 2023 | marketbeat.comTrading was temporarily halted for "BLCM" at 09:05 AM with a stated reason of "LULD pause." Trading set to resume at 09:05 AM. May 8, 2023 | marketbeat.comWhy Is Bellicum Pharmaceuticals (BLCM) Stock Up 75% Today?May 8, 2023 | investorplace.comWhy Digital Brands Group Shares Are Trading Lower By Over 15%; Here Are 20 Stocks Moving PremarketApril 18, 2023 | msn.comShort Volatility Alert: Bellicum PharmaApril 18, 2023 | benzinga.comBLCM Plummets on Stopping Trials of BPX-601 and BPX-603March 15, 2023 | msn.comWhy Bellicum Pharmaceuticals (BLCM) Stock Is Down 48%March 15, 2023 | msn.comBellicum Discontinues Phase 1/2 Trials and Initiates Evaluation of Strategic AlternativesMarch 14, 2023 | finance.yahoo.comTrading was temporarily halted for "BLCM" at 04:03 PM with a stated reason of "News pending."March 14, 2023 | marketbeat.comWhy Bellicum Pharmaceuticals Stock Is Plunging TodayFebruary 24, 2023 | finance.yahoo.comBellicum Presents Early Phase 1 Results for BPX-601 in Prostate Cancer at ASCO GU Cancers SymposiumFebruary 16, 2023 | finance.yahoo.comCORRECTION -- Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)January 31, 2023 | finance.yahoo.comBellicum Pharmaceuticals to Present Early Phase 1 Results for BPX-601 in Prostate Cancer at ASCO 2023 Genitourinary Cancers SymposiumJanuary 19, 2023 | finance.yahoo.comTrading was temporarily halted for "BLCM" at 02:01 PM with a stated reason of "LULD pause."January 6, 2023 | marketbeat.comBellicum Pharmaceuticals, Inc.: Bellicum Reports Third Quarter 2022 Financial Results and Provides Operational UpdateNovember 13, 2022 | finanznachrichten.deBellicum Reports Third Quarter 2022 Financial Results and Provides Operational UpdateNovember 10, 2022 | finance.yahoo.comBellicum Pharmaceuticals to Participate in the 2022 Cell & Gene Meeting on the MesaOctober 4, 2022 | finance.yahoo.comBLCM Bellicum Pharmaceuticals, Inc.September 15, 2022 | seekingalpha.comBellicum Pharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment ConferenceSeptember 1, 2022 | finance.yahoo.comBellicum Pharmaceuticals (BLCM) Could Find Support Soon, Here's Why You Should Buy the Stock NowAugust 25, 2022 | finance.yahoo.comIs Immunocore (IMCR) Stock Outpacing Its Medical Peers This Year?August 18, 2022 | finance.yahoo.comBellicum Reports Second Quarter 2022 Financial Results and Provides Operational UpdateAugust 11, 2022 | finance.yahoo.comBellicum Pharmaceuticals GAAP EPS of -$0.25 beats by $0.42May 13, 2022 | seekingalpha.comBellicum Reports First Quarter 2022 Financial Results and Provides Operational UpdateMay 13, 2022 | finance.yahoo.comBellicum Reports Fourth Quarter 2021 Financial Results and Provides Operational UpdateMarch 24, 2022 | finance.yahoo.comLadenburg Thalmann Initiates Coverage On Bellicum Pharmaceuticals with Buy Rating, Announces Price Target of $5February 16, 2022 | benzinga.comBellicum Pharmaceuticals Inc. BLCMJanuary 28, 2022 | stockhouse.comBellicum Pharmaceuticals to Participate in the B. Riley Securities 2022 Virtual Oncology ConferenceJanuary 26, 2022 | finance.yahoo.comBellicum Regains Compliance with Nasdaq Continued Listing RequirementsDecember 13, 2021 | finance.yahoo.comSumitovant Biopharma Highlights Significant Clinical, Regulatory and Commercial Achievements Across its Portfolio of Companies in the Second Quarter of FY2021December 10, 2021 | finance.yahoo.comBellicum Secures $35M Via Equity Funding, Posts Interim Data From Early GoCAR-T Cancer StudiesDecember 7, 2021 | msn.comBellicum Reports Positive Interim Data From Phase 1/2 GoCAR-T Trials - Quick FactsDecember 6, 2021 | markets.businessinsider.comBellicum Announces Positive Interim Data from Phase 1/2 GoCAR-T® Studies, Secures $35 Million Private Placement Equity Financing Priced at MarketDecember 6, 2021 | finance.yahoo.comK2 BioLabs hiring, expanding contract research offerings for biotech, pharma startupsDecember 2, 2021 | bizjournals.comBellicum Reports Third Quarter 2021 Financial Results and Provides Operational UpdateNovember 4, 2021 | finance.yahoo.comBellicum Pharmaceuticals to Participate in the H.C. Wainwright 23rd Annual Global Investment ...September 3, 2021 | apnews.comBellicum Pharmaceuticals to Participate in the H.C. Wainwright 23rd Annual Global Investment ConferenceSeptember 3, 2021 | finance.yahoo.comBellicum and MD Anderson Announce Additional License Agreement for Use of CaspaCIDe® Safety SwitchSeptember 1, 2021 | finance.yahoo.comBellicum Pharmaceuticals: Q2 Earnings SnapshotAugust 12, 2021 | sfgate.comBellicum Reports Second Quarter 2021 Financial Results and Provides Operational UpdateAugust 12, 2021 | finance.yahoo.com Get Bellicum Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BLCM and its competitors with MarketBeat's FREE daily newsletter. Email Address 📉 Warning: Market Crash Predicted - Secure Your Savings (Ad)The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%. Take these 4 steps to protect your retirement here >>> BLCM Media Mentions By Week BLCM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLCM News Sentiment▼0.340.56▲Average Medical News Sentiment BLCM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLCM Articles This Week▼00▲BLCM Articles Average Week Get Bellicum Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BLCM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alpha Tau Medical News Today BriaCell Therapeutics News Today eFFECTOR Therapeutics News Today Fortress Biotech News Today GeoVax Labs News Today Precigen News Today Unum Group News Today Gilead Sciences News Today Pfizer News Today Novartis News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BLCM) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellicum Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellicum Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
